Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 2.

Stupp, Roger; Taillibert, Sophie; Kanner, Andrew; Read, William; Steinberg, David M; Lhermitte, Benoit; Toms, Steven; Idbaih, Ahmed; Ahluwalia, Manmeet S; Fink, Karen; Di Meco, Francesco; Lieberman, Frank; Zhu, Jay-Jiguang; Stragliotto, Giuseppe; Tran, David D; Brem, Steven; Hottinger, Andreas F; Kirson, Eilon D; Lavy-Shahaf, Gitit; Weinberg, Uri; Kim, Chae-Yong; Paek, Sun-Ha; Nicholas, Garth; Burna, Jordi; Hirte, Hal; Weller, Michael; Palti, Yoram; Hegi, Monika E; Ram, Zvi (2017). Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma. JAMA : the Journal of the American Medical Association, 318(23):2306-2316.

Wick, Wolfgang; Gorlia, Thierry; Bady, Pierre; Platten, Michael; van den Bent, Martin J; Taphoorn, Martin J B; Steuve, Jonathan; Brandes, Alba A; Hamou, Marie-France; Wick, Antje; Kosch, Markus; Weller, Michael; Stupp, Roger; Roth, Patrick; Golfinopoulos, Vassilis; Frenel, Jean-Sebastien; Campone, Mario; Ricard, Damien; Marosi, Christine; VillĂ , Salvador; Weyerbrock, Astrid; Hopkins, Kirsten; Homicsko, Krisztian; Lhermitte, Benoit; Pesce, Gianfranco Angelo; Hegi, Monika E (2016). Phase II study of radiotherapy and temsirolimus versus radiochemotherapy with temozolomide in patients with newly diagnosed glioblastoma without MGMT promoter hypermethylation (EORTC 26082). Clinical Cancer Research, 22(19):4797-4806.

This list was generated on Mon Apr 22 08:33:32 2019 CEST.